NIH-funded research R21 grant

How aging affects the immune system's memory response to infections.

Official title: The impact of senescence on immune memory

Funded at University of Connecticut Sch of Med/dnt · NIH-10646811 · Data updated 2026-11-12

This study looks at how getting older affects our immune system, especially how certain aging cells might make it harder for older adults to remember and fight off the flu, with the goal of finding ways to improve vaccines and boost their immune health.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Connecticut Sch of Med/dnt
NIH-funded
Lab location1 site (Farmington, United States)
Project startSeptember 15, 2023
Project endSeptember 14, 2025
Funding year2023
Award (this year)$453,163
NIH project number1R21AG081678-01
Project IDNIH-10646811 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are older adults, particularly those aged 65 and above, who are at higher risk for severe influenza infections.

Less likely to help

Patients under 21 years old or those without age-related immune decline may not benefit from this research.

What this research studies

This research investigates how age-related changes in the immune system, particularly the accumulation of senescent cells, impact the body's ability to generate protective immune memory after influenza infections. It focuses on understanding the role of these senescent cells in older adults, who often experience a decline in immune response. By examining the mechanisms behind immune memory formation, the study aims to identify potential interventions that could enhance vaccine efficacy and overall immune function in the elderly.

Why it matters

Potential benefit: If successful, this research could lead to improved vaccination strategies and better health outcomes for older adults by enhancing their immune responses.

How similar studies have gone: Previous research has shown that understanding immune responses in aging populations can lead to significant advancements in vaccine development and efficacy.

Where this research is happening

  • University of Connecticut Sch of Med/dnt
    Farmington, United States
    Active

Researchers

  • Principal investigator: Haynes, Laura — University of Connecticut Sch of Med/dnt
  • Study coordinator: Haynes, Laura

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.